ANNOVIS BIO INC. COMMON STOCK
5.3000
27-十二月-24 15:47:37
15 分钟延时
股票
+0.1400
+2.71%
今日范围
5.0300 - 5.3400
ISIN
N/A
来源
NYSE
-
Annovis Bio’s Buntanetap Found Safe and Effective in High-Risk Alzheimer's Patients
11 6月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Annovis Announces New Publication in a Peer-Reviewed Journal
21 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results
13 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
09 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
06 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
29 4月 2024 10:10:00 条件 Nasdaq GlobeNewswire
-
02 4月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
01 4月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
20 3月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024
27 2月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
14 2月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
30 1月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Annovis Bio Refines Timeline for Parkinson’s Phase III Study Data Announcement
24 1月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Annovis Bio to Participate in the 139th Yale CEO Summit
11 12月 2023 13:00:00 条件 Nasdaq GlobeNewswire
-
05 12月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
Annovis Bio Appoints Andrew Walsh as Vice President Finance
01 12月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
27 11月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
Annovis Bio Announces Third Quarter 2023 Financial Results and Provides Corporate Update
08 11月 2023 17:00:00 条件 Nasdaq GlobeNewswire
-
12 10月 2023 08:02:38 条件 Nasdaq GlobeNewswire
-
Annovis Bio Announces First Quarter 2023 Financial Results and Provides Corporate Update
11 5月 2023 07:00:01 条件 Nasdaq GlobeNewswire